| ULS00232 |
UDP-4-deoxy-4-formamido-beta-L-arabinose from UDP-alpha-D-glucuronate |
None - {{∅}} |
None - {{∅}} |
Unexplained |
|
| UER00493 |
UDP-4-deoxy-4-formamido-beta-L-arabinose from UDP-alpha-D-glucuronate: step 2/3~1 L-glutamate + 1 UDP-beta-L-threo-pentopyranos-4-ulose => 1 2-oxoglutarate + 1 UDP-4-amino-4-deoxy-L-arabinose. |
None - {{∅}} |
None - {{∅}} |
Unexplained |
|
| UPA00032 |
UDP-4-deoxy-4-formamido-beta-L-arabinose biosynthesis~Biosynthesis of UDP-beta-(4-deoxy-4-formamido-L-arabinose) (UDP-L-Ara4FN), a precursor of 4-amino-4-deoxy-L-arabinose (L-Ara4N). This latter compound is covalently linked to lipid A moiety of some pathogenic Gram-negative bacteria. This LPS modification is a strategy adopted by pathogenic Gram-negative bacteria to evade cationic antimicrobial peptides produced by the innate immune system. |
None - {{∅}} |
None - {{∅}} |
Unexplained |
|
| UER00494 |
UDP-4-deoxy-4-formamido-beta-L-arabinose from UDP-alpha-D-glucuronate: step 3/3~1 10-formyl-5,6,7,8-tetrahydrofolate + 1 UDP-4-amino-4-deoxy-L-arabinose => 1 5,6,7,8-tetrahydrofolate + 1 UDP-4-deoxy-4-formamido-beta-L-arabinose. |
None - {{∅}} |
None - {{∅}} |
Unexplained |
|
| UER00492 |
UDP-4-deoxy-4-formamido-beta-L-arabinose from UDP-alpha-D-glucuronate: step 1/3~1 NAD(+) + 1 UDP-alpha-D-glucuronate => 1 CO(2) + 1 H(+) + 1 NADH + 1 UDP-beta-L-threo-pentopyranos-4-ulose. |
None - {{∅}} |
None - {{∅}} |
Unexplained |
|